Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 198,955 | 96,363 | 194,905 | 4,762 | 59,640 |
| Marketable Securities | 862,941 | 1,228,499 | 1,140,445 | 291,370 | 329,462 |
| Receivables | 38,889 | 36,802 | 43,213 | 5,014 | 15,678 |
| Inventories | 15,292 | 12,665 | 11,381 | 10,726 | 11,109 |
| Other current assets | 21,928 | 47,221 | 47,743 | 14,948 | 10,063 |
| TOTAL | $1,138,005 | $1,421,550 | $1,437,687 | $326,820 | $425,952 |
| Non-Current Assets | |||||
| PPE Net | 59,662 | 65,665 | 48,851 | 47,463 | 65,601 |
| Investments And Advances | 136,662 | 279,119 | 582,889 | 57,088 | 0 |
| Intangibles | 76,501 | 76,501 | 76,501 | 76,501 | 76,501 |
| Other Non-Current Assets | 127,937 | 134,521 | 4,244 | 994 | 817 |
| TOTAL | $400,762 | $555,806 | $712,485 | $182,046 | $142,919 |
| Total Assets | $1,538,767 | $1,977,356 | $2,150,172 | $508,866 | $568,871 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 252,891 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 22,139 | 19,234 | 5,854 | 4,782 | 2,816 |
| Accrued Expenses | 58,739 | 51,397 | 52,676 | 25,767 | 30,436 |
| Other current liabilities | N/A | N/A | 493 | 446 | 19,907 |
| TOTAL | $115,779 | $353,893 | $82,002 | $56,163 | $72,222 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 246,950 | 245,207 | 243,464 |
| Deferred Revenues | N/A | 5,517 | 13,892 | 18,949 | 14,352 |
| Other Non-Current Liabilities | 345,693 | 215,518 | 92,901 | 100,647 | 113,173 |
| TOTAL | $345,693 | $218,072 | $350,595 | $364,875 | $408,524 |
| Total Liabilities | $461,472 | $571,965 | $432,597 | $421,038 | $480,746 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,152 | 11,843 | 11,613 | 10,734 | 10,261 |
| Common Shares | 18 | 17 | 17 | 15 | 15 |
| Retained earnings | -2,309,158 | -1,864,718 | -1,424,051 | -2,117,941 | -2,021,010 |
| Other shareholders' equity | -2,295 | -1,005 | -6,316 | -2,111 | -2,363 |
| TOTAL | $1,077,295 | $1,405,391 | $1,717,575 | $87,828 | $88,125 |
| Total Liabilities And Equity | $1,538,767 | $1,977,356 | $2,150,172 | $508,866 | $568,871 |